PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage

A Vichalkovski1, E Gresko, D Hess

  • 1Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, Basel, Switzerland.

Oncogene
|April 20, 2010
PubMed

Insights

Protein kinase B (PKB/Akt) promotes cancer cell survival by phosphorylating Twist-1, inhibiting p53

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Protein kinase B (PKB/Akt) is crucial for cell survival and is often upregulated in cancers.
  • PKB/Akt regulates various cellular processes through phosphorylation of target proteins.
  • The anti-apoptotic protein Twist-1 plays a role in cancer progression.

Purpose of the Study:

  • To investigate the role of PKB/Akt in regulating the anti-apoptotic protein Twist-1.
  • To determine the functional consequences of PKB/Akt-mediated phosphorylation of Twist-1.
  • To explore the implications of this interaction in cancer development.

Main Methods:

  • In vitro phosphorylation assays to identify PKB/Akt targets.
  • Cellular studies using wild-type and mutant Twist-1.
  • DNA damage induction using gamma-irradiation and adriamycin.
  • Analysis of p53, p21(Waf1), and Bax expression.
  • In vivo studies in human cancer tissues.

Main Results:

  • PKB/Akt directly phosphorylates the anti-apoptotic protein Twist-1 at Serine 42.
  • Phosphorylation of Twist-1 by PKB/Akt impairs p53 upregulation following DNA damage.
  • This leads to reduced activation of p53 target genes, aberrant cell-cycle regulation, and inhibition of apoptosis.
  • A Twist-1 S42A mutant failed to confer resistance to DNA damage, confirming PKB/Akt-dependent phosphorylation's role.
  • Phosphorylation of Twist-1 at Ser42 was observed in human cancer tissues.

Conclusions:

  • PKB/Akt-mediated phosphorylation of Twist-1 at Ser42 is a key mechanism for promoting cancer cell survival.
  • This post-translational modification inhibits the p53 tumor suppressor pathway, contributing to carcinogenesis.
  • Targeting the PKB/Akt-Twist-1 interaction may offer therapeutic strategies for cancer treatment.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...